| |
| |
|
| Insider
Information: |
Staab Thomas R Ii |
| Relationship: |
|
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
284,110 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,522,546 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
284,110 |
|
|
| Total
Value |
$1,522,546 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 5.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
Senior Vice President ... |
2019-05-17 |
125,176 |
2011-07-01 |
0 |
Premium* |
|
|
Lensar, Inc. |
LNSR |
|
2024-05-06 |
158,934 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
123 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFOO |
• – – |
2011-07-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
| LNSR |
Lensar, Inc. |
Chief Financial OfficerOfficer |
• – – |
2020-09-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
96,381 |
|
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2018-11-19 |
4 |
AS |
$8.30 |
$623 |
D/D |
(75) |
137,383 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2018-11-19 |
4 |
OE |
$3.78 |
$284 |
D/D |
75 |
137,458 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2018-11-05 |
4 |
OE |
$3.22 |
$692 |
D/D |
215 |
137,598 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2018-11-05 |
4 |
AS |
$8.00 |
$1,720 |
D/D |
(215) |
137,383 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2014-03-01 |
4 |
D |
$11.69 |
$5,389 |
D/D |
(461) |
126,616 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2015-03-01 |
4 |
D |
$10.20 |
$4,743 |
D/D |
(465) |
165,144 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2016-03-01 |
4 |
D |
$2.13 |
$990 |
D/D |
(465) |
144,628 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2013-03-01 |
4 |
D |
$1.19 |
$645 |
D/D |
(542) |
49,322 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2018-11-07 |
4 |
AS |
$8.00 |
$5,376 |
D/D |
(672) |
137,383 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2018-11-07 |
4 |
OE |
$3.22 |
$2,164 |
D/D |
672 |
138,055 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Chief Financial Officer |
• – – |
2022-12-07 |
4 |
B |
$3.16 |
$2,294 |
D/D |
727 |
135,131 |
2.66 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-01-01 |
4 |
D |
$8.07 |
$6,335 |
D/D |
(785) |
132,676 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2018-01-01 |
4 |
D |
$4.91 |
$4,183 |
D/D |
(852) |
141,362 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2018-10-03 |
4 |
AS |
$7.26 |
$7,802 |
D/D |
(1,072) |
137,383 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2018-10-03 |
4 |
OE |
$3.22 |
$3,508 |
D/D |
1,072 |
137,483 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2016-08-11 |
4 |
S |
$5.05 |
$6,595 |
D/D |
(1,306) |
128,745 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2016-01-01 |
4 |
D |
$10.32 |
$17,296 |
D/D |
(1,676) |
134,916 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2017-01-01 |
4 |
D |
$6.33 |
$10,609 |
D/D |
(1,676) |
122,511 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Chief Financial Officer |
• – – |
2024-01-11 |
4 |
D |
$4.43 |
$8,209 |
D/D |
(1,853) |
139,934 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Chief Financial Officer |
• – – |
2022-12-06 |
4 |
B |
$3.16 |
$6,403 |
D/D |
2,025 |
134,404 |
2.74 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2014-01-01 |
4 |
D |
$7.60 |
$18,643 |
D/D |
(2,453) |
49,614 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2015-01-01 |
4 |
D |
$12.16 |
$29,828 |
D/D |
(2,453) |
169,389 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-17 |
4 |
AS |
$7.45 |
$18,625 |
D/D |
(2,500) |
125,176 |
0 |
- |
|
123 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
